Citation: Nannan Fan, Zhen Zhang, Huiyan Zu, Xinkui Liu, Bin Wang, Xiuming Miao, Chu Chu, Yunhong Zhang, Xiaoxiao Zhu, Ping Li, Xia Li. Targeting disulfidptosis for ovarian cancer therapy induced by nanodrugs carrying 6-aminonicotinamide[J]. Chinese Chemical Letters, ;2026, 37(8): 111812. doi: 10.1016/j.cclet.2025.111812 shu

Targeting disulfidptosis for ovarian cancer therapy induced by nanodrugs carrying 6-aminonicotinamide

Nannan Fan ^{a, 1} ,
Zhen Zhang ^{a, 1} ,
Huiyan Zu ^a ,
Xinkui Liu ^a ,
Bin Wang ^b ,
Xiuming Miao ^c ,
Chu Chu ^a ,
Yunhong Zhang ^a ,
Xiaoxiao Zhu ^a ,
Ping Li ^{a, d, *,} ,
Xia Li ^{a, e, *,}

a.
Innovative Institute of Chinese Medicine and Pharmacy, Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Jinan Key Laboratory of Traditional Chinese Medicine Immuneregulation, Traditional Chinese Medicine Immuneregulation Engineering Research Center of Shandong Province, Shandong University of Traditional Chinese Medicine, Ji’nan 250014, China
b.
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji’nan 250001, China
c.
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji’nan 250014, China
d.
College of Chemistry and Chemical Engineering, Northwest Normal University, Lanzhou 730070, China
e.
College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Ji’nan 250355, China

ip@sdnu.edu.cn

60230033@sdutcm.edu.cn

Received Date: 14 May 2025
Revised Date: 5 September 2025
Accepted Date: 8 September 2025
Available Online: 9 September 2025

Figures(4)

Ovarian cancer (OC) manifests the second deadliest gynecologic malignancy and shows severe conventional therapies-resistance, underscoring the urgent need for new therapeutic interventions. Disulfidptosis, caused in solute carrier family 7 member 11 (SLC7A11)-overexpressing (SLC7A11^high) cancer cells under glucose deficiency, has emerged as an appealing alternative approach. Herein we identified the significantly high expression of SLC7A11 in OC, and demonstrated that disulfidptosis induced by 6-aminonicotinamide (6-AN) effectively kill SLC7A11^high OC cells. Hence, to enhance the therapeutic effect of 6-AN, we engineered a novel nanodrug, FA-L@AI, utilizing folic acid (FA)-modified liposome, and also illustrated the detailed therapeutic mechanism. Upon exposed to FA-L@AI, SLC7A11^high OC cells endured internal nicotinamide adenine dinucleotide phosphate (NADPH) pools deleting, which leads to cystine accumulations. The elevated cystine levels resulted in disulfide bonds formation in actin cytoskeletal protein, ultimately triggering disulfidptosis. FA-L@AI nanoparticles exhibited an impactful suppression of tumor cells growth through 6-AN-induced disulfidptosis both in vitro and in vivo. Consistently, mRNA transcriptomic analysis further elucidated the underlying mechanism of disulfidptosis. Altogether, our work displays a unique strategy mediating disulfidptosis for OC specific therapy.
- Antitumor agents,
- Nanoparticles,
- 6-Aminonicotinamide,
- Disulfidptosis,
- Ovarian cancer therapy
1. [1]
  S. Lheureux, M. Braunstein, M. Amit, CA Cancer J. Clin. 69 (2019) 280–304. doi: 10.3322/caac.21559
2. [2]
  R.L. Siegel, K.D. Miller, N.S. Wagle, CA Cancer J. Clin. 73 (2023) 17–48. doi: 10.3322/caac.21763
3. [3]
  J.D. Seidman, S.I. Horkayne, M. Haiba, et al., Int. J. Gynecol. Pathol. 23 (2004) 41–44. doi: 10.1097/01.pgp.0000101080.35393.16
4. [4]
  D. Cortes-Guiral, M. Huebner, M. Alyami, et al., Nat. Rev. Dis. Primers 7 (2021) 91. doi: 10.1038/s41572-021-00326-6
5. [5]
  C. Yang, B.R. Xia, Z.C. Zhang, et al., Front. Immunol. 11 (2020) 577869. doi: 10.3389/fimmu.2020.577869
6. [6]
  L. Yu, Y.J. Xu, Z.J. Pu, et al., J. Am. Chem. Soc. 144 (2022) 11326–11337. doi: 10.1021/jacs.2c03256
7. [7]
  Y.H. Fu, Y.C. He, X.D. Wei, et al., ACS Nano 18 (2024) 28793–28809. doi: 10.1021/acsnano.4c08468
8. [8]
  Y.X. Zhang, Q.Y. Jia, J. Li, et al., Adv. Mater. 35 (2023) 2305073. doi: 10.1002/adma.202305073
9. [9]
  J.J. Cheng, L.L. Duo, D. Jin, et al., Angew. Chem. Int. Ed. 136 (2024) e202319982. doi: 10.1002/ange.202319982
10. [10]
  X.L. Zhang, Y.X. Liu, H. Li, et al., Chin. Chem. Lett. 37 (2026) 111404. doi: 10.1016/j.cclet.2025.111404
11. [11]
  S.Q. Zhang, J.X. Li, X. Hu, et al., Chin. Chem. Lett. 36 (2025) 110314. doi: 10.1016/j.cclet.2024.110314
12. [12]
  X.Z. Wang, S.S. He, P.H. Cheng, K.Y. Pu, Adv. Mater. 35 (2023) 2206510. doi: 10.1002/adma.202206510
13. [13]
  T.C. Do, J.W. Lau, C.X. Sun, et al., Sci. Adv. 8 (2022) 2216. doi: 10.1126/sciadv.abq2216
14. [14]
  C.S. Shin, P. Mishra, J.D. Watrous, et al., Nat. Commun. 8 (2017) 15074. doi: 10.1038/ncomms15074
15. [15]
  P. Koppula, Y. Zhang, J.J. Shi, et al., J. Biol. Chem. 292 (2017) 14240–14249. doi: 10.1074/jbc.M117.798405
16. [16]
  T. Goji, K. Takahara, M. Negishi, H. Katoh, J. Biol. Chem. 292 (2017) 19721–19732. doi: 10.1074/jbc.M117.814392
17. [17]
  L.M. Machesky, Nat. Cell. Biol. 25 (2023) 375–376. doi: 10.1038/s41556-023-01100-4
18. [18]
  X.G. Liu, L. Zhuang, B.Y. Gan, Trends. Cell Biol. 34 (2024) 327–337. doi: 10.3390/horticulturae10040327
19. [19]
  X. Liu, L. Nie, Y. Zhang, et al., Nat. Cell Biol. 25 (2023) 404–414. doi: 10.1038/s41556-023-01091-2
20. [20]
  W.Y. Zhen, Y.J. Fan, T. Germanas, et al., Adv. Mater. 37 (2025) 2405494. doi: 10.1002/adma.202405494
21. [21]
  Y.L. Zhu, X.X. Wang, L.L. Feng, et al., Nat. Commun. 15 (2024) 8696. doi: 10.1038/s41467-024-53135-2
22. [22]
  S. Guo, Z.H. Li, R.L. Zhou, et al., Small 20 (2024) 2309842. doi: 10.1002/smll.202309842
23. [23]
  A. Mohanty, A. Mohapatra, W. Yang, et al., Adv. Healthc. Mater. 14 (2025) 2500272. doi: 10.1002/adhm.202500272
24. [24]
  W.Y. Zhen, T.Z. Zhao, X.Y. Chen, J.J. Zhang, Small 21 (2025) 2500880. doi: 10.1002/smll.202500880
25. [25]
  X.D. Wu, S.Z. Shen, J.L. Qin, et al., BJOG 129 (2022) 40–49. doi: 10.1111/1471-0528.17327
26. [26]
  I. Giacomini, E. Ragazzi, G. Pasut, M. Montopoli, Int. J. Mol. Sci. 21 (2020) 937. doi: 10.3390/ijms21030937
27. [27]
  C.X. Wang, C.X. Yu, H.K. Chang, et al., Expert. Opin. Ther. Targt. 27 (2023) 733–743. doi: 10.1080/14728222.2023.2247558
28. [28]
  Z. Song, S. Wang, L. Lu, et al., Metabolites 12 (2022) 1227. doi: 10.3390/metabo12121227
29. [29]
  C.L. Song, Z.J. Jiao, Z.F. Hou, et al., J. Am. Chem. Soc. 145 (2023) 21860–21870. doi: 10.1021/jacs.3c05948
30. [30]
  X.C. Fu, Y.M. Huang, H. Zhao, et al., Adv. Mater. 33 (2021) 2102570. doi: 10.1002/adma.202102570
31. [31]
  X.Y. Li, H. Liu, W.Y. Gao, et al., Adv. Mater. 36 (2024) 2311291. doi: 10.1002/adma.202311291
32. [32]
  X.Z. Lian, S. Chatterjee, Y.H. Sun, et al., Nat. Nanotechnol. 19 (2024) 1409–1417. doi: 10.1038/s41565-024-01680-8
33. [33]
  M.M. Rahman, J. Wang, G.S. Wang, et al., Nat. Nanotechnol. 19 (2024) 818–824. doi: 10.1038/s41565-024-01620-6
34. [34]
  W. Zhang, L. Ngo, S.C.H. Tsao, et al., ACS Appl. Mater. Interfaces 15 (2023) 16420–16433. doi: 10.1021/acsami.2c22749
35. [35]
  J. Song, N. Zhang, L. Zhang, et al., Int. J. Nanomed. 14 (2019) 2757–2772. doi: 10.2147/ijn.s203108
36. [36]
  S.Y. Han, P. Dwivedi, F.A. Mangrio, et al., Artif. Cell Nanomed. B 47 (2019) 957–967. doi: 10.1080/21691401.2019.1576705
37. [37]
  L.X. Li, D. He, Q.Q. Guo, J. Nanobiotechnol. 20 (2022) 50. doi: 10.1186/s12951-022-01264-5
38. [38]
  C. Risnayanti, Y.S. Jang, J.J. Lee, H.J. Ahn, Sci. Rep. 8 (2018) 7498. doi: 10.1038/s41598-018-25930-7
39. [39]
  L.Y. Jiang, H. Wang, S.Z. Chen, J. Nanosci. Nanotechnol. 20 (2020) 2025–2031. doi: 10.1166/jnn.2020.17301
40. [40]
  N.B. Mutlu-Agardan, C. Sarisozen, V.P. Torchilin, Pharm. Res. 37 (2020) 65. doi: 10.1007/s11095-020-2759-4
41. [41]
  G.M. Dam, G. Themelis, L.M.A. Crane, et al., Nat. Med. 17 (2021) 1315–1319.
42. [42]
  G. Jo, B.Y. Lee, E.J. Kim, M.H. Park, H. Hyun, Biomedicines 8 (2020) 476. doi: 10.3390/biomedicines8110476
43. [43]
  C. Ying, S.F. Wang, F. Zhang, Nat. Rev. Bioeng. 1 (2023) 60–78. doi: 10.1038/s44222-022-00002-8
44. [44]
  W. Li, S.L. Yin, Y. Shen, L. Yuan, X.B. Zhang, J. Am. Chem. Soc. 145 (2023) 3736–3747. doi: 10.1021/jacs.2c13222
45. [45]
  M. Zhang, W.T. Wang, M. Mohammadniaei, et al., Adv. Mater. 33 (2021) 2008802. doi: 10.1002/adma.202008802
46. [46]
  W.Q. Meng, A.C. Sedgwick, N. Kwon, et al., J. Chem. Soc. Rev. 52 (2023) 601. doi: 10.1039/d2cs00650b
47. [47]
  X.L. Wang, B.B. Ding, W. Liu, et al., J. Am. Chem. Soc. 146 (2024) 17854–17865. doi: 10.1021/jacs.4c03478
48. [48]
  M.S. Khan, B.H.J. Gowda, W.H. Almalki, et al., Drug Discov. Today 29 (2024) 103819. doi: 10.1016/j.drudis.2023.103819
49. [49]
  A. Gabizon, H. Shmeeda, A.T. Horowitz, S. Zalipsky, Adv. Drug Deliv. Rev. 56 (2004) 1177–1192. doi: 10.1016/j.addr.2004.01.011
50. [50]
  R.K. Hylton, J.E. Heebner, M.A. Grillo, M.T. Swulius, Nat. Commun. 13 (2022) 2439. doi: 10.1038/s41467-022-30116-x
51. [51]
  M.J. Shi, X.Y. Li, Y. Guo, et al., Adv. Sci. 12 (2024) 2411131.
52. [52]
  M.S. Almeida, E. Susnik, B. Drasler, et al., Chem. Soc. Rev. 50 (2021) 5397. doi: 10.1039/D0CS01127D
53. [53]
  Z. Li, Y.B. Zhu, H.W. Zeng, et al., Nat. Commun. 14 (2023) 1437. doi: 10.1038/s41467-023-37150-3
54. [54]
  A. Gabizon, A.T. Horowitz, D. Goren, et al., Clin. Cancer Res. 9 (2003) 6551–6559.
1. [1]
  Shangqian Zhang , Jiaxuan Li , Xuan Hu , Zelong Chen , Junliang Dong , Chenhao Hu , Shuang Chao , Yinghua Lv , Yuxin Pei , Zhichao Pei . H₂S and NIR light-driven nanomotors induce disulfidptosis for targeted anticancer therapy by enhancing disruption of tumor metabolic symbiosis. Chinese Chemical Letters, 2025, 36(1): 110314-. doi: 10.1016/j.cclet.2024.110314
2. [2]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
3. [3]
  Wei Su , Xiaoyan Luo , Peiyuan Li , Ying Zhang , Chenxiang Lin , Kang Wang , Jianzhuang Jiang . Phthalocyanine self-assembled nanoparticles for type Ⅰ photodynamic antibacterial therapy. Chinese Chemical Letters, 2024, 35(12): 109522-. doi: 10.1016/j.cclet.2024.109522
4. [4]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
5. [5]
  Lian Jin , Juan Zhang , Libo Nie , Yan Deng , Ghulam Jilany Khana , Nongyue He . Chitosan nanoparticles act as promising carriers of microRNAs to brain cells in neurodegenerative diseases. Chinese Chemical Letters, 2025, 36(10): 110774-. doi: 10.1016/j.cclet.2024.110774
6. [6]
  Yuwen Zhu , Xiang Deng , Yan Wu , Baode Shen , Lingyu Hang , Yuye Xue , Hailong Yuan . Formation mechanism of herpetrione self-assembled nanoparticles based on pH-driven method. Chinese Chemical Letters, 2025, 36(1): 109733-. doi: 10.1016/j.cclet.2024.109733
7. [7]
  Mengdie Li , Shundong Cai , Hongjin Li , Yuhang Cheng , Jinfa Ye , Lang Ke , Yun Han , Min Su , Gang Liu , Chengchao Chu . Nanotherapeutics for ocular posterior segment diseases therapy: Towards its advances and challenges. Chinese Chemical Letters, 2026, 37(5): 111392-. doi: 10.1016/j.cclet.2025.111392
8. [8]
  Yihao Zhang , Yang Jiao , Xianchao Jia , Qiaojia Guo , Chunying Duan . Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor. Chinese Chemical Letters, 2024, 35(5): 108748-. doi: 10.1016/j.cclet.2023.108748
9. [9]
  Tianxia Chen , Yunhui Chen , Weiwei Li , Peipei Cen , Yan Guo , Jin Zhang , Cunding Kong , Xiangyu Liu . Fabricating AuAg-nanoparticles/ZIF-8 composites for selective detection and efficient extraction of dinitroaniline pesticides. Chinese Chemical Letters, 2025, 36(8): 110214-. doi: 10.1016/j.cclet.2024.110214
10. [10]
  Zhongxin Duan , Yue Wang , Yunchu Zhang , Xia Liu , Wanyu Wang , Hua Li , Qingyang Lu , Chao You , Yongzhong Cheng , Cong Wu , Xiang Gao . Intranasal pterostilbene nanoparticles delivery alleviates neuroinflammation and brain injury after intracerebral hemorrhage. Chinese Chemical Letters, 2026, 37(5): 111248-. doi: 10.1016/j.cclet.2025.111248
11. [11]
  Yixin Zhang , Ting Wang , Jixiang Zhang , Pengyu Lu , Neng Shi , Liqiang Zhang , Weiran Zhu , Nongyue He . Formation mechanism for stable system of nanoparticle/protein corona and phospholipid membrane. Chinese Chemical Letters, 2024, 35(4): 108619-. doi: 10.1016/j.cclet.2023.108619
12. [12]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
13. [13]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
14. [14]
  Fereshte Hassanzadeh-Afruzi , Mina Azizi , Iman Zare , Ehsan Nazarzadeh Zare , Anwarul Hasan , Siavash Iravani , Pooyan Makvandi , Yi Xu . Advanced metal-organic frameworks-polymer platforms for accelerated dermal wound healing. Chinese Chemical Letters, 2024, 35(11): 109564-. doi: 10.1016/j.cclet.2024.109564
15. [15]
  Shenglan Zhou , Haijian Li , Hongyi Gao , Ang Li , Tian Li , Shanshan Cheng , Jingjing Wang , Jitti Kasemchainan , Jianhua Yi , Fengqi Zhao , Wengang Qu . Recent advances in metal-loaded MOFs photocatalysts: From single atom, cluster to nanoparticle. Chinese Chemical Letters, 2025, 36(1): 110142-. doi: 10.1016/j.cclet.2024.110142
16. [16]
  Liangyu Zhang , Lei Lei , Zhuangzhuang Zhao , Guizhi Yang , Kaitao Wang , Liying Wang , Ningxin Zhang , Yanjia Ai , Xinqing Ma , Guannan Liu , Meng Zhao , Jun Wu , Dongjun Lin , Chun Chen . Enhanced venetoclax delivery using l-phenylalanine nanocarriers in acute myeloid leukemia treatment. Chinese Chemical Letters, 2025, 36(6): 110316-. doi: 10.1016/j.cclet.2024.110316
17. [17]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
18. [18]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656
19. [19]
  Jin Wang , Xiaoyan Pan , Junyu Zhang , Qingqing Zhang , Yanchen Li , Weiwei Guo , Jie Zhang . Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters, 2024, 35(8): 109187-. doi: 10.1016/j.cclet.2023.109187
20. [20]
  Boyuan Liu , Zixu Liu , Ping Wang , Yu Zhang , Haibing He , Tian Yin , Jingxin Gou , Xing Tang . Nanomedicine-based targeting delivery systems for peritoneal cavity localized therapy: A promising treatment of ovarian cancer and its peritoneal metastasis. Chinese Chemical Letters, 2025, 36(6): 110229-. doi: 10.1016/j.cclet.2024.110229

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(23)
HTML views(1)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142